CNBX Pharmaceuticals Inc. (CNBX) Asset Utilization Ratio (2016 - 2024)
CNBX Pharmaceuticals' (CNBX) quarterly Asset Utilization Ratio came in at 1.51 in Q4 2024, up 34.29% YoY from 1.13 in Q4 2023, and down 35.17% on a QoQ basis from 2.34 in Q3 2024.
CNBX Pharmaceuticals Inc. (CNBX) Asset Utilization Ratio (2016 - 2024) Analysis & Trends
CNBX Pharmaceuticals (CNBX) has 9 years of Asset Utilization Ratio data on file, last reported at 1.51 in Q4 2024.
- Quarterly Asset Utilization Ratio rose 34.29% year-over-year to 1.51 in Q4 2024, while the trailing twelve-month figure through Nov 2024 was 1.51 (up 34.29% YoY) and the FY2024 annual result came in at 0.49, down 21.67% from the prior year.
- Asset Utilization Ratio eased to 1.51 in Q4 2024, from 2.34 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 2.34 in Q3 2024 to a low of 0.0 in Q2 2021.
- A 5-year average of 0.64 and a median of 0.05 in 2022 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2021 — Asset Utilization Ratio tumbled 67.32% — and 2024, when it jumped 3404.99%.
- Tracing CNBX's Asset Utilization Ratio over 5 years: stood at 0.0 in 2020, then sank by 81.75% to 0.0 in 2021, then surged by 8278.02% to 0.04 in 2022, then jumped by 2572.74% to 1.13 in 2023, then surged by 34.29% to 1.51 in 2024.
- The last three Asset Utilization Ratio figures came in at 1.51 (Q4 2024), 2.34 (Q3 2024), and 1.89 (Q2 2024), per Business Quant data.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2024 | 1.51 |
| Aug 31, 2024 | 2.34 |
| May 31, 2024 | 1.89 |
| Feb 29, 2024 | 1.96 |
| Nov 30, 2023 | 1.13 |
| Aug 31, 2023 | 0.71 |
| May 31, 2023 | 0.61 |
| Feb 28, 2023 | 0.06 |
| Nov 30, 2022 | 0.04 |
| Aug 31, 2022 | 0.03 |
| May 31, 2021 | 0.00 |
| Feb 28, 2021 | 0.00 |
| Nov 30, 2020 | 0.00 |
| Aug 31, 2020 | 0.00 |
| May 31, 2020 | 0.00 |
| Feb 29, 2020 | 0.00 |
| Nov 30, 2019 | 0.00 |
| Aug 31, 2019 | 0.00 |
| May 31, 2019 | 0.00 |
| Feb 28, 2019 | 0.00 |